Location History:
- Lyon, FR (2018)
- Lyons, FR (2016 - 2020)
- Sérézin du Rhône, FR (2021)
Company Filing History:
Years Active: 2016-2021
Title: The Innovations of Frederic Batt
Introduction
Frederic Batt is a notable inventor based in Lyons, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective NK-3 receptor antagonists. With a total of four patents to his name, Batt's work is characterized by innovative approaches to therapeutic treatments.
Latest Patents
Frederic Batt's latest patents include the development of chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines. These compounds serve as selective NK-3 receptor antagonists and are aimed at addressing NK-3 receptor mediated disorders. The patents detail a novel chiral synthesis of these compounds using N-sp3 protective groups, along with intermediates for their synthesis. This innovative approach highlights Batt's commitment to advancing therapeutic options in the pharmaceutical industry.
Career Highlights
Throughout his career, Frederic Batt has worked with prominent companies such as Ogeda and Euroscreen. His experience in these organizations has allowed him to refine his expertise in drug development and synthesis. Batt's contributions have been instrumental in pushing the boundaries of pharmaceutical research.
Collaborations
Frederic Batt has collaborated with notable professionals in his field, including Hamid R. Hoveyda and Guillaume Dutheuil. These collaborations have fostered a rich exchange of ideas and have contributed to the success of his innovative projects.
Conclusion
Frederic Batt's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect a dedication to improving therapeutic treatments through scientific advancement. Batt continues to be a significant figure in the realm of drug development.